Table 1.
Patients' demographic and baseline characteristics.
| Characteristics | Values |
|---|---|
| Number of patients | 786 |
| GI bleeding | 64 (8.1) |
| Age, median (IQR), yrs | 58 (52–66) |
| Gender | |
| Male (N, %) | 497(63.2) |
| Female (N, %) | 289 (36.8) |
| Medical history | |
| Smoking (N, %) | 87 (11.1) |
| Alcohol (N, %) | 71 (9.0) |
| Hypertension (N, %) | 525 (66.8) |
| Diabetes mellitus (N, %) | 117 (14.9) |
| Prior anticoagulation or antiplatelet therapy (N, %) | 41 (5.2) |
| Time from symptom onset to initial CT, hours, median (IQR) | 4.0 (3.0–5.0) |
| Baseline GCS score, median (IQR) | 11.0 (8.0–13.0) |
| Baseline volume (N, %) | |
| < 30 ml | 553 (70.4) |
| ≥30 ml | 233 (29.6) |
| Intraventricular hemorrhage (N, %) | 200 (25.4) |
| ICH location (n, %) | |
| Deep | 60.2 (76.6) |
| Lobar | 114 (14.5) |
| Brain stem | 29 (3.7) |
| Cerebellum | 40 (5.1) |
| Hematoma expansion (N, %) | 81 (10.3) |
| Age-to-GCS ratio, median (IQR) | 5.40 (4.31–7.11) |
| Hemoglobin (g/L) | 151.00 (138.0–163.0) |
| Coagulation function, median (IQR) | |
| Platelets (109/L) | 172.0 (136.0–212.25) |
| aPTT, s | 24.80 (21.20–28.70) |
| INR | 1.01 (0.94–1.07) |
| Prothrombin time, s | 11.40 (10.80–12.0) |
| Fibrinogen, g/L | 2.87 (2.40–3.40) |
| Thrombin time, s | 17.30 (15.00–18.60) |
| MV used > 48 h (N, %) | 128 (16.3) |
| Surgery (N, %) | 353 (44.9) |
| Hospital length of stay, median (IQR), days | 16.0 (10.0–23.0) |
| Modified ranking scale (N, %) | |
| 0–2 | 328 (41.7) |
| 3–6 | 458 (58.3) |
aPTT, activated partial thromboplastin time; CT, computed tomography; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; INR, international normalized ratio; IQR, interquartile range; MV, mechanical ventilation.